RT Journal Article
SR Electronic
T1 Excess mortality across regions of Europe during the first wave of the COVID-19 pandemic – impact of the winter holiday travelling and government responses
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.24.20237644
DO 10.1101/2020.11.24.20237644
A1 Björk, Jonas
A1 Mattisson, Kristoffer
A1 Ahlbom, Anders
YR 2020
UL http://medrxiv.org/content/early/2020/11/24/2020.11.24.20237644.abstract
AB Background This aggregated population study of 219 regions in 11 European countries investigated the effect of the seemingly quasi-randomly assigned school winter holiday week on excess mortality associated with the COVID-19 pandemic during spring 2020. A secondary aim was to evaluate the impact of stringency and timing of the government responses to the early inflow of infected cases.Methods Regional data on mortality week 14-23 in 2020 compared with the same period 2015-2019 were retrieved from Eurostat and national statistical agencies. Data on initial government responses were obtained from the Oxford COVID-19 Government Response Tracker. Variance-weighted least square regression was used with further adjustment for population density and age distribution.Results Being a region with winter holiday exclusively in week 9 was in the adjusted analysis associated with 16 weekly excess deaths (95% confidence interval 13 to 20) per million inhabitants, which corresponds to 38% of the excess mortality during the study period in these regions. A more stringent response implemented in week 11, corresponding to 10 additional units on the 0-100 ordinal scale, was associated with 20 fewer weekly deaths (95% confidence interval 18 to 22) per million inhabitants.Conclusions Travelling during winter holiday in week 9 was an amplifying event that contributed importantly to the excess mortality observed in the study area during the spring 2020. Timely government responses to the resulting early inflow of cases was associated with lower excess mortality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Swedish Research Council [grant number 2019-00198].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was entirely based on aggregated population data why no ethical approval was necessary.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe present study was based on secondary, aggregated data that are hosted and maintained by the Lund University Population Research Platform (LUPOP), and can be made available on request. https://www.lupop.lu.se/ https://www.lupop.lu.se/